Kaléo Responds Regarding Auvi-Q Family of Auto-Injectors in Light of Spectrum Labs Epinephrine Recall


As we reported Tuesday, Spectrum Laboratory Products issued a worldwide recall of certain lots of their powdered epinephrine used to manufacture finished dose products that treat a variety of life-threatening conditions including anaphylaxis.

Although some number of hospitals, clinics, and physicians’ offices will no doubt be affected, we reached out to the manufacturers of auto-injectors marketed in the US — Viatris (formerly Mylan for EpiPen, EpiPen Jr), Kaléo (Auvi-Q), Amneal (Adrenaclick generic), Teva (EpiPen generic) and Adamis (Symjepi) — to find out if their products were affected by the recall.

Click to visit sponsor

Caryn Foster Durham, Senior Director, Corporate Communications for Kaléo — states the Auvi-Q family of auto-injectors is NOT affected by the recall:

Our thanks to Ms Durham for her prompt reply which will put the minds of many owners of Auvi-Q at ease.

Click here to see Viatris’ response regarding EpiPen.

We will post the statements of the remaining manufacturers as we receive them.

Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.

Find Allergy-Friendly Products